Ladies and gentlemen, thank you so much for standing by and welcome to 10x Genomics First Quarter ... great advances to single cell analysis. Visium HD has become a leading approach for unbiased ...

Despite a challenging macro environment, 10x Genomics Inc (TXG) showcases resilience with strong consumables growth and ...

As you might know, 10x Genomics, Inc. (NASDAQ:TXG) just kicked off its latest quarterly results with some very strong numbers. The results overall were pretty good, with revenues of US$155m ...

10x Genomics TXG has been analyzed by 12 analysts ... microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 9.8% year on year to $154.9 million. On the other hand, next quarter’s ...

10X GENOMICS ($TXG) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of -$0.36 per share, beating estimates of -$0.48 by $0.12 ...

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $34.4 million in its first quarter. The Pleasanton, California-based company said it ...